Clinical Trials Browser

OTHER_GOV × Interventional × Breast Cancer Metastatic × Clear all

NCT00532714 2011-12-30

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

Phase 2 Completed

Breast Cancer Metastatic